Trodusquemine: Interim Phase I data

Interim data from a double-blind, placebo-controlled Phase I trial in 28 obese or overweight Type II diabetic volunteers, showed that single IV doses of 3, 6, 10 and 15 mg/m 2 trodusquemine were well ...